We are particularly interested in understanding the conditions for which free VEGF in the tumor decreases following anti-VEGF treatment, which corresponds to a fold-change in tumor VEGF less than one and is termed a therapeutic effect. This evidence concerns the gene VEGFA and neoplasm.